These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24565005)

  • 41. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
    Lindemann L; Porter RH; Scharf SH; Kuennecke B; Bruns A; von Kienlin M; Harrison AC; Paehler A; Funk C; Gloge A; Schneider M; Parrott NJ; Polonchuk L; Niederhauser U; Morairty SR; Kilduff TS; Vieira E; Kolczewski S; Wichmann J; Hartung T; Honer M; Borroni E; Moreau JL; Prinssen E; Spooren W; Wettstein JG; Jaeschke G
    J Pharmacol Exp Ther; 2015 Apr; 353(1):213-33. PubMed ID: 25665805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression.
    Wang Y; Fan R; Huang X
    J Ethnopharmacol; 2012 Jun; 141(2):571-7. PubMed ID: 21933701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antidepressants prevent hierarchy destabilization induced by lipopolysaccharide administration in mice: a neurobiological approach to depression.
    Cohn DW; Kinoshita D; Palermo-Neto J
    Ann N Y Acad Sci; 2012 Jul; 1262():67-73. PubMed ID: 22823437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacotherapy of depression: recent developments].
    Baumann P
    Rev Med Suisse; 2007 Sep; 3(125):2079-80, 2083-4. PubMed ID: 17939526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Neurobiology and Promising New Treatment in Depression.
    Jeon SW; Kim YK
    Int J Mol Sci; 2016 Mar; 17(3):381. PubMed ID: 26999106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Methodical problems of clinical-psychopharmacological research presented using the example of antidepressive agents].
    Bente D
    Arzneimittelforschung; 1969 May; 19(5):806-8. PubMed ID: 4895502
    [No Abstract]   [Full Text] [Related]  

  • 47. [Progress of new antidepressant drugs development].
    Zhang X; Tian JS; Liu H; Qin XM
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):29-33. PubMed ID: 28945021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokines, "depression due to a general medical condition," and antidepressant drugs.
    Yirmiya R; Weidenfeld J; Pollak Y; Morag M; Morag A; Avitsur R; Barak O; Reichenberg A; Cohen E; Shavit Y; Ovadia H
    Adv Exp Med Biol; 1999; 461():283-316. PubMed ID: 10442179
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microarray analysis in drug discovery: an uplifting view of depression.
    Levy SE
    Sci STKE; 2003 Oct; 2003(206):pe46. PubMed ID: 14583588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical sex differences in depression and antidepressant response: Implications for clinical research.
    Kokras N; Dalla C
    J Neurosci Res; 2017 Jan; 95(1-2):731-736. PubMed ID: 27870451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action.
    Cottingham C; Ferryman CJ; Wang Q
    Prog Mol Biol Transl Sci; 2015; 132():207-25. PubMed ID: 26055060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Criticisms of drugs in early development for the treatment of depression: what can be improved?
    Wang SM; Han C; Pae CU
    Expert Opin Investig Drugs; 2015 Apr; 24(4):445-53. PubMed ID: 25529224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Promising New Strategy to Improve Treatment Outcomes for Patients with Depression.
    Carpenter G; Harbin HT; Smith RL; Hornberger J; Nash DB
    Popul Health Manag; 2019 Jun; 22(3):223-228. PubMed ID: 30156460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The application of antidepressant drugs in cancer treatment.
    Zheng Y; Chang X; Huang Y; He D
    Biomed Pharmacother; 2023 Jan; 157():113985. PubMed ID: 36402031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depression drug disappoints.
    Ledford H
    Nature; 2011 Nov; 479(7373):278. PubMed ID: 22094666
    [No Abstract]   [Full Text] [Related]  

  • 57. Hypothalamic dysfunction and antidepressant drugs.
    McLeod WR; Carroll BJ; Davies B
    Br Med J; 1970 May; 1(5707):480-1. PubMed ID: 5420217
    [No Abstract]   [Full Text] [Related]  

  • 58. Are Electroencephalogram-Derived Predictors of Antidepressant Efficacy Closer to Clinical Usefulness?
    Iosifescu DV
    JAMA Netw Open; 2020 Jun; 3(6):e207133. PubMed ID: 32568395
    [No Abstract]   [Full Text] [Related]  

  • 59. Autophagy-based antidepressants?
    Kapczinski F; Montezano BB; Nardi AE; Lledo PM; Katsimpardi L
    Braz J Psychiatry; 2023; 45(3):203-4. PubMed ID: 37062586
    [No Abstract]   [Full Text] [Related]  

  • 60. [New approaches to discover antidepressants targeting stress-related pathways].
    Iijima M; Shimazaki T; Yoshimizu T; Karasawa J; Chaki S
    Nihon Yakurigaku Zasshi; 2010 Sep; 136(3):137-40. PubMed ID: 20838014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.